Crossmark

Comment on: "Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database."

Crossref DOI link: https://doi.org/10.1007/s40261-024-01407-6

Published Online: 2024-12-24

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Noguchi, Yoshihiro https://orcid.org/0000-0002-9110-9604
Suzuki, Keiko https://orcid.org/0000-0001-9924-7991
Ino, Yoko https://orcid.org/0000-0003-2195-1385
Yoshimura, Tomoaki https://orcid.org/0009-0008-2486-8169
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (22K12890)
License Information

Text and Data Mining valid from 2024-12-24

Version of Record valid from 2024-12-24
More Information

Article History

Accepted: 30 October 2024

First Online: 24 December 2024

Declarations

:

: This paper was supported by JSPS KAKENHI Grant number 22K12890.

: The authors have no competing interests.

: Not applicable.

: Not applicable.

: Not applicable.

: Data sharing is not applicable to this article as no datasets were generated or analyzed during this letter.

: Not applicable.

: Yoshihiro Noguchi: conceptualization, writing—original draft, writing—review and editing. Keiko Suzuki And Yoko Ino: writing—review and editing. Tomoaki Yoshimura: writing—review and editing, supervision. All authors read and approved the final version.

Document is current

Any future updates will be listed below